Health experts at Kenneth K. Wogensen, MD, have rounded up the most overlooked early warning signs and 'subtle symptoms' of ...

Scientists have long observed that cancer patients have a lower risk of Alzheimer’s disease. New research reveals a possible ...

Alzheimer’s may be driven far more by genetics than previously thought, with one gene playing an outsized role. Researchers ...

The experimental drug lecanemab shows "potential" as an Alzheimer's disease treatment, according to new Phase 3 trial results, but the findings raise some safety concerns because of its association ...

A new blood test that could help doctors identify whether a patient has Alzheimer’s disease was cleared by the FDA last week. The diagnostic tool, the Elecsys pTau 181 plasma test, is developed by ...

Dementia is a group of brain disorders that cause a decline in cognitive functions like memory and thinking. While some cognitive decline is a natural part of aging, dementia is an extreme version ...

Following the hard-won success of early anti-amyloid drugs, a new generation of Alzheimer’s modalities—from tau-targeting ...

Scientists have found a possible explanation for why cancer patients are less likely to develop Alzheimer's. The enemy of our ...

Alzheimer's disease continues to be one of the great challenges of modern neurology, and few professionals approach it with as much passion and rigour as award-winning neurologist Dr. Pablo ...

Alzheimer’s Awareness Month may refer to several observances that aim to highlight the frequency and severity of Alzheimer’s disease, support current patients, promote cognitive health and raise money ...